Key Dates

Related Announcements

RFA-CA-21-040 - Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)

Issued by

National Cancer Institute (NCI)

Purpose

This Notice corrects the Instructions for the Submission of Multi-Component Applications in Funding Opportunity Announcement (FOA) RFA-CA-21-040, "Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)".

The following section of the FOA has been revised:

Currently Reads:

Section IV. Application and Submission Information

2. Content and Form of Application Submission

Instructions for the Submission of Multi-Component Applications

The following section supplements the instructions found in the SF424 (R&R) Application Guide, and should be used for preparing a multi-component application.

The application should consist of the following components:

• Overall: required; maximum of 1
• Administrative Core: required; maximum of 1
• Research Project: required; minimum of 2
• Shared Resource Cores: required; maximum of 2
• Cross-Training Core: required; maximum of 1

Modified to Read (changes shown in bold italics):

Section IV. Application and Submission Information

2. Content and Form of Application Submission

Instructions for the Submission of Multi-Component Applications

The following section supplements the instructions found in the SF424 (R&R) Application Guide, and should be used for preparing a multi-component application.

The application should consist of the following components:

• Overall: required; maximum of 1
• Administrative Core: required; maximum of 1
• Molecular Characterization Trial: required; maximum of 1
• Research Project: required; minimum of 2
• Shared Resource Cores: required; maximum of 2
• Cross-Training Core: required; maximum of 1

All other aspects of RFA-CA-21-040 remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Michael Graham Espey, Ph.D. 
National Cancer Institute (NCI)
Telephone: 240-276-7619
Email: SP@nih.gov

Jeffrey Buchsbaum, M.D., Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5690
Email: jeff.buchsbaum@nih.gov

Bhadrasain (Vik) Vikram, M.D.
National Cancer Institute (NCI)
Telephone: 240-276-5690
Email: vikramb@mail.nih.gov

Peer Review Contact(s)

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov